Cargando…
Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study
BACKGROUND: Early diagnosis and treatment of esophageal squamous cell dysplasia (ESCdys) and esophageal squamous cell carcinoma (ESCC) could significantly reduce the incidence and mortality of ESCC. This pilot study aimed to investigate whether P16/CDKN2A methylation could serve as a cytologic bioma...
Autores principales: | Fan, Zhiyuan, Qin, Yu, Zhou, Jing, Chen, Ru, Gu, Jianhua, Li, Minjuan, Zhou, Jiachen, Li, Xinqing, Lin, Dongmei, Wang, Jinwu, Deng, Dajun, Wei, Wenqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636512/ https://www.ncbi.nlm.nih.gov/pubmed/35352503 http://dx.doi.org/10.1002/cam4.4718 |
Ejemplares similares
-
Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy
por: Qin, Yu, et al.
Publicado: (2021) -
Microbial and epidemiological factors in early detection of esophageal squamous cell carcinoma and precancerous lesions
por: Li, Minjuan, et al.
Publicado: (2023) -
Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020) -
Risk Prediction Model for Esophageal Cancer Among General Population: A Systematic Review
por: Chen, Ru, et al.
Publicado: (2021) -
Associations between cancer family history and esophageal cancer and precancerous lesions in high-risk areas of China
por: Zhou, Jiachen, et al.
Publicado: (2022)